Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment

13 Jul 2022

Abstract excerpt

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with devastating consequences for the global economy and human health. According to the World Health Organization, COVID-19 has affected more than 481 million people worldwide, with 6 million confirmed deaths. The joint efforts of the scientific community...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35884998
DOI: 10.3390/biomedicines10071690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity AssessmentPMID 35884998Read ↗

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read ↗

Proteomics Analysis of Serum from COVID-19 PatientsSemantic proximity Read ↗

Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 DiseaseSemantic proximity Read ↗

High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversionSemantic proximity Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID‐19 progressionSemantic proximity Read ↗

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read ↗

Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patientsSemantic proximity Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

Discovery Proteomics for COVID-19: Where We Are NowSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.